173.06
Natera Inc Borsa (NTRA) Ultime notizie
Natera, Inc. Experiences Revision in Stock Evaluation Amid Strong Market Performance - Markets Mojo
Can volume confirm reversal in Natera Inc.Weekly Gains Report & Precise Swing Trade Alerts - newser.com
Natera, Inc. Forms Golden Cross, Signaling Potential Bullish Breakout Ahead - Markets Mojo
Natera, Inc. $NTRA Position Increased by Narwhal Capital Management - MarketBeat
QRG Capital Management Inc. Increases Position in Natera, Inc. $NTRA - MarketBeat
Natera Inc Stock Analysis and ForecastTrading Volume Surges & Compound Your Gains With Quality Stocks - earlytimes.in
Truist Financial Corp Purchases 4,525 Shares of Natera, Inc. $NTRA - MarketBeat
What drives Natera Inc stock priceDividend Yield Trends & Low Cost Portfolio Ideas - earlytimes.in
Chart based exit strategy for Natera Inc.2025 Market WrapUp & Safe Capital Growth Tips - newser.com
Why Natera Inc. stock remains on buy listsJuly 2025 Momentum & Verified Momentum Watchlists - newser.com
Is Natera Inc. building a consolidation base2025 Stock Rankings & Precise Swing Trade Entry Alerts - newser.com
Mirae Asset Global Investments Co. Ltd. Purchases 2,837 Shares of Natera, Inc. $NTRA - MarketBeat
How institutional ownership impacts Natera Inc. stockJuly 2025 Technicals & Fast Exit Strategy with Risk Control - newser.com
Natera's Enrollment Surge in EXPAND Trial Could Be a Game Changer for Natera (NTRA) - simplywall.st
Combining machine learning predictions for Natera Inc.Market Weekly Review & Weekly Chart Analysis and Trade Guides - newser.com
Natera, Inc. $NTRA Shares Purchased by ASR Vermogensbeheer N.V. - MarketBeat
Barclays Keeps Their Buy Rating on Natera (NTRA) - The Globe and Mail
Natera (NTRA): Exploring Valuation as Share Price Pulls Back Despite Strong Growth - simplywall.st
Natera (NTRA): Assessing Valuation Potential as Shares Enter a Quiet Phase - simplywall.st
Is Natera Inc. a candidate for recovery play2025 AllTime Highs & Accurate Trade Setup Notifications - newser.com
Natera Stock (NTRA) Opinions on EXPAND Trial Enrollment and Insider Sales - Quiver Quantitative
Natera (NASDAQ:NTRA) Insider Sells $479,970.00 in Stock - MarketBeat
Natera CEO Chapman sells $3.7m in stock By Investing.com - Investing.com Australia
Enrollment Tops 1,600 in Natera’s EXPAND Trial of Single Gene NIPT - BioSpace
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing - Investing.com Nigeria
Natera (NASDAQ:NTRA) CFO Sells $403,666.55 in Stock - MarketBeat
Insider Sell: Solomon Moshkevich Sells 3,000 Shares of Natera In - GuruFocus
Natera (NTRA) sec. Rabinowitz sells $221k in shares By Investing.com - Investing.com Australia
Natera CFO Brophy sells $403,673 in shares By Investing.com - Investing.com South Africa
Natera CEO Chapman sells $3.7m in stock - Investing.com India
Natera (NTRA) sec. Rabinowitz sells $221k in shares - Investing.com India
Natera CFO Brophy sells $403,673 in shares - Investing.com India
Natera Inc: president Moshkevich sells $479k in stock By Investing.com - Investing.com South Africa
Natera Inc: president Moshkevich sells $479k in stock - Investing.com India
Natera, Inc. Experiences Revision in Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Why Natera’s Stock is Gaining Attention - TipRanks
Natera (NTRA) Achieves Key Enrollment Milestone in EXPAND Trial - GuruFocus
Natera enrolls over 1,600 patients in EXPAND trial for fetal testing By Investing.com - Investing.com South Africa
Ninety One UK Ltd Has $95.11 Million Holdings in Natera, Inc. $NTRA - MarketBeat
Natera Announces Publication of Signatera™ Validation Study in Testicular Cancer - BioSpace
Insider Selling: Natera (NASDAQ:NTRA) CEO Sells 14,083 Shares of Stock - MarketBeat
Natera’s ctDNA test outperforms standard markers in testicular cancer By Investing.com - Investing.com Nigeria
Natera’s ctDNA test outperforms standard markers in testicular cancer - Investing.com India
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):